CAPLIN POINT LABORATORIES
|
CAPLIN POINT LABORATORIES Last 5 Year Balance Sheet History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr |
Equity - Authorised | ₹17 Cr | ₹17 Cr | ₹17 Cr | ₹17 Cr | ₹17 Cr |
Equity - Issued | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr |
Equity Paid Up | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | ₹75 Cr | ₹75 Cr | ₹75 Cr | ₹75 Cr | ₹75 Cr |
Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
Share Warrants & Outstandings | ₹20 Cr | ₹14 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr |
Total Reserves | ₹2,741 Cr | ₹2,212 Cr | ₹1,775 Cr | ₹1,379 Cr | ₹1,081 Cr |
Securities Premium | ₹161 Cr | ₹157 Cr | ₹155 Cr | ₹150 Cr | ₹146 Cr |
Capital Reserves | ₹95 Cr | ₹3.21 Cr | ₹3.21 Cr | ₹3.21 Cr | ₹2.86 Cr |
Profit & Loss Account Balance | ₹2,369 Cr | ₹1,963 Cr | ₹1,540 Cr | ₹1,191 Cr | ₹914 Cr |
General Reserves | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr |
Other Reserves | ₹104 Cr | ₹77 Cr | ₹66 Cr | ₹23 Cr | ₹7.23 Cr |
Reserve excluding Revaluation Reserve | ₹2,741 Cr | ₹2,212 Cr | ₹1,775 Cr | ₹1,379 Cr | ₹1,081 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹2,850 Cr | ₹2,316 Cr | ₹1,880 Cr | ₹1,484 Cr | ₹1,186 Cr |
Minority Interest | ₹36 Cr | ₹31 Cr | ₹27 Cr | ₹26 Cr | ₹18 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-2.23 Cr | ₹-13 Cr | ₹-14 Cr | ₹-6.21 Cr | ₹1.16 Cr |
Deferred Tax Assets | ₹15 Cr | ₹25 Cr | ₹30 Cr | ₹30 Cr | ₹20 Cr |
Deferred Tax Liability | ₹13 Cr | ₹12 Cr | ₹16 Cr | ₹24 Cr | ₹21 Cr |
Other Long Term Liabilities | ₹14 Cr | ₹11 Cr | ₹8.35 Cr | ₹10 Cr | ₹11 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹1.74 Cr | ₹9.04 Cr | ₹7.78 Cr | ₹8.48 Cr | ₹5.69 Cr |
Total Non-Current Liabilities | ₹13 Cr | ₹7.89 Cr | ₹2.13 Cr | ₹13 Cr | ₹17 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹218 Cr | ₹230 Cr | ₹153 Cr | ₹156 Cr | ₹89 Cr |
Sundry Creditors | ₹218 Cr | ₹230 Cr | ₹153 Cr | ₹156 Cr | ₹89 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹64 Cr | ₹90 Cr | ₹100 Cr | ₹49 Cr | ₹52 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹12 Cr | ₹31 Cr | ₹23 Cr | ₹5.49 Cr | - |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹52 Cr | ₹59 Cr | ₹77 Cr | ₹43 Cr | ₹52 Cr |
Short Term Borrowings | ₹0.55 Cr | ₹0.28 Cr | ₹3.41 Cr | ₹0.50 Cr | - |
Secured ST Loans repayable on Demands | - | - | - | - | - |
Working Capital Loans- Sec | - | - | - | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹0.55 Cr | ₹0.28 Cr | ₹3.41 Cr | ₹0.50 Cr | - |
Short Term Provisions | ₹24 Cr | ₹11 Cr | ₹12 Cr | ₹2.56 Cr | ₹2.48 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | - | - | - | - | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹24 Cr | ₹11 Cr | ₹12 Cr | ₹2.56 Cr | ₹2.48 Cr |
Total Current Liabilities | ₹306 Cr | ₹331 Cr | ₹268 Cr | ₹208 Cr | ₹143 Cr |
Total Liabilities | ₹3,206 Cr | ₹2,686 Cr | ₹2,177 Cr | ₹1,730 Cr | ₹1,364 Cr |
ASSETS | |||||
Gross Block | ₹860 Cr | ₹702 Cr | ₹480 Cr | ₹446 Cr | ₹423 Cr |
Less: Accumulated Depreciation | ₹314 Cr | ₹250 Cr | ₹201 Cr | ₹159 Cr | ₹117 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹546 Cr | ₹453 Cr | ₹280 Cr | ₹287 Cr | ₹305 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹139 Cr | ₹117 Cr | ₹220 Cr | ₹15 Cr | ₹14 Cr |
Non Current Investments | ₹279 Cr | ₹138 Cr | ₹71 Cr | ₹37 Cr | ₹0.66 Cr |
Long Term Investment | ₹279 Cr | ₹138 Cr | ₹71 Cr | ₹37 Cr | ₹0.66 Cr |
Quoted | ₹0.92 Cr | ₹1.09 Cr | ₹0.74 Cr | ₹0.60 Cr | ₹0.66 Cr |
Unquoted | ₹278 Cr | ₹137 Cr | ₹70 Cr | ₹36 Cr | - |
Long Term Loans & Advances | ₹89 Cr | ₹78 Cr | ₹52 Cr | ₹90 Cr | ₹7.92 Cr |
Other Non Current Assets | ₹15 Cr | ₹7.43 Cr | ₹2.66 Cr | ₹1.08 Cr | ₹21 Cr |
Total Non-Current Assets | ₹1,072 Cr | ₹793 Cr | ₹625 Cr | ₹432 Cr | ₹349 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹311 Cr | ₹238 Cr | ₹210 Cr | ₹52 Cr | ₹11 Cr |
Quoted | ₹96 Cr | ₹36 Cr | ₹20 Cr | ₹52 Cr | - |
Unquoted | ₹215 Cr | ₹202 Cr | ₹190 Cr | - | ₹11 Cr |
Inventories | ₹336 Cr | ₹363 Cr | ₹288 Cr | ₹227 Cr | ₹179 Cr |
Raw Materials | ₹48 Cr | ₹41 Cr | ₹39 Cr | ₹32 Cr | ₹22 Cr |
Work-in Progress | ₹6.44 Cr | ₹6.81 Cr | ₹8.88 Cr | ₹6.67 Cr | ₹3.09 Cr |
Finished Goods | ₹45 Cr | ₹49 Cr | ₹14 Cr | ₹18 Cr | ₹4.73 Cr |
Packing Materials | ₹32 Cr | ₹28 Cr | ₹28 Cr | ₹21 Cr | ₹20 Cr |
Stores  and Spare | ₹12 Cr | ₹11 Cr | ₹13 Cr | ₹13 Cr | ₹7.31 Cr |
Other Inventory | ₹193 Cr | ₹227 Cr | ₹186 Cr | ₹137 Cr | ₹122 Cr |
Sundry Debtors | ₹632 Cr | ₹543 Cr | ₹394 Cr | ₹317 Cr | ₹279 Cr |
Debtors more than Six months | ₹149 Cr | ₹83 Cr | ₹3.78 Cr | - | - |
Debtors Others | ₹483 Cr | ₹460 Cr | ₹390 Cr | ₹317 Cr | ₹279 Cr |
Cash and Bank | ₹591 Cr | ₹553 Cr | ₹493 Cr | ₹463 Cr | ₹438 Cr |
Cash in hand | ₹0.22 Cr | ₹0.14 Cr | ₹1.49 Cr | ₹2.54 Cr | ₹2.66 Cr |
Balances at Bank | ₹591 Cr | ₹553 Cr | ₹492 Cr | ₹460 Cr | ₹436 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹77 Cr | ₹50 Cr | ₹23 Cr | ₹14 Cr | ₹20 Cr |
Interest accrued on Investments | ₹29 Cr | ₹17 Cr | ₹19 Cr | ₹12 Cr | ₹8.44 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹14 Cr | ₹1.80 Cr | ₹2.37 Cr | - | - |
Other current_assets | ₹35 Cr | ₹32 Cr | ₹1.80 Cr | ₹1.27 Cr | ₹12 Cr |
Short Term Loans and Advances | ₹186 Cr | ₹146 Cr | ₹143 Cr | ₹225 Cr | ₹87 Cr |
Advances recoverable in cash or in kind | ₹75 Cr | ₹62 Cr | ₹72 Cr | ₹62 Cr | ₹42 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | ₹119 Cr | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹111 Cr | ₹84 Cr | ₹71 Cr | ₹44 Cr | ₹45 Cr |
Total Current Assets | ₹2,134 Cr | ₹1,893 Cr | ₹1,552 Cr | ₹1,298 Cr | ₹1,015 Cr |
Net Current Assets (Including Current Investments) | ₹1,828 Cr | ₹1,562 Cr | ₹1,284 Cr | ₹1,090 Cr | ₹872 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹3,206 Cr | ₹2,686 Cr | ₹2,177 Cr | ₹1,730 Cr | ₹1,364 Cr |
Contingent Liabilities | ₹0.64 Cr | ₹0.64 Cr | ₹0.64 Cr | ₹0.71 Cr | ₹1.02 Cr |
Total Debt | ₹0.55 Cr | ₹0.28 Cr | ₹3.41 Cr | ₹0.50 Cr | ₹17 Cr |
Book Value | 362.67 | 293.21 | 235.91 | 183.89 | 144.94 |
Adjusted Book Value | 362.67 | 293.21 | 235.91 | 183.89 | 144.94 |
Compare Balance Sheet of peers of CAPLIN POINT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CAPLIN POINT LABORATORIES | ₹17,719.4 Cr | 4.2% | 8.3% | 16.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹388,752.0 Cr | 0.7% | -0.7% | -13.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,626.0 Cr | 0.6% | -1.9% | 10.9% | Stock Analytics | |
CIPLA | ₹125,951.0 Cr | -0.1% | -0.3% | -6.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,932.0 Cr | -1% | -3% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,414.0 Cr | 0.6% | 3.7% | -1.6% | Stock Analytics |
CAPLIN POINT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CAPLIN POINT LABORATORIES | 4.2% |
8.3% |
16.4% |
SENSEX | 1.6% |
2.6% |
-0.3% |
You may also like the below Video Courses